  |
Lægemiddelstofklassifikation ATC |
M | ||
  |
Antineoplastiske og immunomodulerende midler |
ML | ||
   |
immunsuppressiva |
ML04 | ||
 |
immunsuppressiva |
ML04A | ||
|
komplementhæmmere |
ML04AJ | ||
 |
eculizumab |
ML04AJ01 | ||
 |
ravulizumab |
ML04AJ02 | ||
 |
pegcetacoplan |
ML04AJ03 | ||
 |
sutimlimab |
ML04AJ04 | ||
 |
avacopan |
ML04AJ05 | ||
 |
zilucoplan |
ML04AJ06 | ||
 |
crovalimab |
ML04AJ07 | ||
 |
iptacopan |
ML04AJ08 | ||
 |
danicopan |
ML04AJ09 | ||
 |
vilobelimab |
ML04AJ10 |
TEXT